A flowchart algorithm for the neurologist to discuss and attend sexual issues in Parkinson’s disease
Objective: To propose guidelines for neurologists to discuss sexual issues and offer education and practical solutions. Background: Sexual dysfunction (SD) is a common nonmotor symptom…Clinical hypnosis in functional movement disorders: a potential therapeutic strategy
Objective: To present a patient with a functional movement disorder who was successfully treated with clinical hypnosis. Background: Functional movement disorders (FMD), specially fixed dystonia,…The effect of intranasal oxytocin in patients with functional motor symptoms: an open label case series
Objective: Aim of this case series was to assess the effect of a single dose of intranasal oxytocin in a sample of patients with FMS…The role of attention in functional movement disorders
Objective: Identify where the attentional focus naturally lies in functional movement disorders and evaluate which abnormal attentional foci contribute to symptom generation. The ultimate aim…Long Term Follow Up Following Multidisciplinary Inpatient Rehabilitation for Functional Movement Disorders
Objective: To assess the maintenance of improvement in Functional Movement Disorders (FMDs) following inpatient rehabilitation one year after discharge. Background: FMDs are chronic and challenging…Opinions and clinical practices related to diagnosing and managing patients with functional (psychogenic) movement disorders: from 2009 to 2019
Objective: (1) To examine current opinion and clinical practices related to diagnosis and management of Functional Movement Disorders (FMD); and (2) to determine if practice…Botulinum Neurotoxin (BoNT) treatment in functional movement disorders: an extended follow up
Objective: To assess the long term effect of treatment with botulinum neurotoxin (BoNT) in patients with functional jerky or tremorous movement disorders. Background: Treatment options for…Neuropsychiatric disorders in observed patients with Parkinson’s disease
Objective: Parkinson's disease (PD), - chronic progressive disease of the brain from the degeneration of the nigrostriatal neurons in the basal ganglia and impaired function.…Botulinum Neurotoxin (BoNT) for treatment of functional (psychogenic) jerky movement disorders: a randomized placebo-controlled clinical trial
Objective: To assess the effectiveness of botulinum neurotoxin (BonT) in patients with functional jerky movement disorders Background: At least 2–9% of patients seen in movement…Treatment of Functional Neurological Disorders: Towards Expert Consensus Led Guidelines for the American Neuropsychiatric Association Committee for Research
Objective: To develop evidence-based, expert consensus recommendations for the treatment of functional neurological disorders (FND) on behalf of the ANPA Committee for Research. Background: FND…